Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Merck Canada Inc. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
The aim of the present study is to answer the question whether deep neuromuscular blockade has a clinically significant impact on intra and postoperative pain, opioid requirement and anesthesia related outcomes and side effects for the early phase of recovery (24hs) after colorectal laparoscopic surgery.
Background: For the last decade many studies have reported that intraoperative surgical and anesthesia conditions might have an impact of postoperative pain.
The most recent surgical literature agrees on the fact the IAP should remain under 15mmhg or even 12mmhg during the whole laparoscopic surgery, and many efforts to do so were developed in the most recent years. On the anesthesia side, deep neuromuscular block was associated with better postoperative recovery when looking at pain parameters such as pain scores and opioid requirements. Nevertheless, all these previous studies, even if recent, did not properly evaluate intraoperative pain and did not well control criteria used to guide the administration of intraoperative opioids, one of the main components of anesthesia. Also, lots of these studies did not properly evaluate or control the depth of hypnosis, another main component of anesthesia. Nowadays, new monitors with extremely better sensitivity and specificity are available for each of the anesthesia component. This might completely revisit the previous findings in the literature and offer much better-quality results. Maisonneuve-Rosemont Hospital in Montreal is a unique center that has invested in new monitors to evaluate each of these anesthesia component: BIS index for depth of hypnosis (BIS device, Covidien, Saint-Laurent, Canada), NOL index (PM-200TM device, Medasense LTD, Ramat Gan, Israel) for nociceptive evaluation (intra-operative pain assessment under general anesthesia), and TOF-scan (NMB monitor, Drager, Mississauga, Canada) for quantitative and 3D evaluation of the depth of muscle relaxation.
This study will answer the question whether deep neuromuscular blockade has a clinically significant impact on intra and postoperative pain, opioid requirement and anesthesia related outcomes and side effects for the early phase of recovery (24hs) after colorectal laparoscopic surgery.
This study will be conducted in a single center, and will be an open label, single blinded, randomized controlled study. Type of surgery: laparoscopic colorectal surgery with anesthesia time expected to last more than 120min in ASA 1-3 patients, fully consented for primary colorectal laparoscopic surgery.
The primary objective of the study: To compare total intra-operative remifentanil consumption during anesthesia for laparoscopic colorectal surgery between two groups: Group "D" for Deep muscle relaxation and group "M" for Moderate muscle relaxation. Secondary objectives are listed below. For an expected decrease of 25% in the remifentanil intraoperative consumption per hour of surgery (in mcg) of surgery, with a type I error α = 0.05 (two-tailed), a 90% power, the total sample size needed is 82 (41 per group). To account for an approximative 20% rate of loss to follow-up or missing data due to technical problems, a total of 100 subjects will be recruited.
Study Duration: 24 months. Study Center: Maisonneuve-Rosemont Hospital, CIUSSS de l'Est de l'Ile de Montreal (CEMTL), University of Montreal, Montreal, Quebec, Canada.
Adverse Events: None expected. Subvention: An Independent Investigator Initiated Trial (IIIT) grant application has been accepted by the company Merck (see letter attached) for the sponsoring of this study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group "M" for Moderate muscle relaxation, low doses rocuronium | Active Comparator | A bolus of 0.4 mg/kg of IV rocuronium will be given at the induction of the anesthesia. Rocuronium IV bolus guided by TOF that must remain between 1-3 / 4 during surgery. |
|
| Group "D" for Deep muscle relaxation, high doses rocuronium | Experimental | A bolus of 0.4 mg/kg of IV rocuronium will be given at the induction of the anesthesia. Bolus of rocuronium 0.1 mg/kg IV will be given during surgery to keep the TOF 0/4 and a PTC ≤ 2 (parameters measured every 10 minutes). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rocuronium IV bolus 0.1 mg/kg guided by TOF that must remain between 1-3 during surgery | Drug | Bolus of rocuronium 0.1 mg/kg at the discretion of anesthetist to keep the TOF between 1-3 out of 4 during surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Total intra-operative remifentanil consumption during surgery in mcg/kg/h | To compare total intra-operative remifentanil consumption (in mcg per hour from T0 incision until Tend = start dressing) during anesthesia for laparoscopic colorectal surgery between two groups: Group "D" for Deep muscle relaxation and group "M" for Moderate muscle relaxation | Intra-operative (from T0 incision until Tend = start dressing) |
| Measure | Description | Time Frame |
|---|---|---|
| Number of IV boluses and increases of remifentanil infusion, number, no unit | To compare the number of IV boluses and increases of remifentanil infusion needed in group D versus M | Intra-operative (from T0 incision until Tend = start dressing) |
| Number of times NOL index passes over the threshold of 25, number, no unit |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Philippe PR Richebé, MD PhD | Contact | 514-743-6558 | philippe.richebe@umontreal.ca | |
| Nadia NG Godin, RC and RN | Contact | 514-525-3400 | 3193 | ngodin.hmr@ssss.gouv.qc.ca |
| Name | Affiliation | Role |
|---|---|---|
| Philippe PR Richebé, MD PhD | CIUSSS Est de l'île de Montréal | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montréal | Recruiting | Montreal East | Quebec | H1T2M4 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 39447530 | Derived | Morisson L, Harkouk H, Othenin-Girard A, Oulehri W, Laferriere-Langlois P, Belanger ME, Idrissi M, Godin N, Verdonck O, Fortier LP, Poirier M, Henri M, Latulippe JF, Tremblay JF, Trepanier JS, Bendavid Y, Raft J, Richebe P. Impact of deep neuromuscular blockade on intraoperative NOL-guided remifentanil requirement during desflurane anesthesia in laparoscopic colorectal surgeries: A randomised controlled trial. J Clin Anesth. 2024 Dec;99:111659. doi: 10.1016/j.jclinane.2024.111659. Epub 2024 Oct 23. |
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jul 17, 2023 | |
| Reset | Mar 1, 2024 | |
| Release | Mar 20, 2024 |
Not provided
Tow groups of patients. Randomization into group "D" for Deep muscle relaxation vs group "M" for Moderate muscle relaxation according to a randomization list for a total number of 100 patients
Not provided
Not provided
Randomization into group "D" for Deep muscle relaxation (high doses of intraoperative rocuronium and antagonization at the end with 4mg/kg of suggamadex) vs group "M" for Moderate muscle relaxation (moderate doses of intraoperative rocuronium and antagonization at the end with suggamadex 2mg/kg) will be done prior to the entrance in the OR, the day of the surgery
| Rocuronium IV bolus 0.1 mg/kg guided by TOF 0/4 and PTC≤ 2 | Drug | Bolus of rocuronium 0.1 mg/kg IV will be given during surgery for a TOF 0/4 and a PTC ≤ 2 (parameters measured every 10 minutes). |
|
To compare the number of times NOL index passes over the threshold of 25 (considered as painful threshold in an anesthetized patient) during anesthesia in group D versus M |
| Intra-operative (from T0 incision until Tend = start dressing) |
| Area Under the Curve (AUCs) whenever the NOL is above 25, no unit | To compare the Area Under the Curve (AUCs) of all the intraoperative periods for which the NOL index will be above the pain threshold of 25 from T0 until Tend | Intra-operative (from T0 incision until Tend = start dressing) |
| Total intraoperative time from T0 until Tend with NOL above 25 in minutes | To compare the total intraoperative time in minutes from T0 until Tend with NOL index above 25, with NOL index between 10 and 25, and with NOL index below 10 in group D versus M | Intra-operative (from T0 incision until Tend = start dressing) |
| Intraoperative level of intra-abdominal pressure (IAP) in mmHg | To compare between group D versus M the intraoperative level of intra-abdominal pressure (IAP) to keep a surgeons' satisfaction score (Leiden Surgical Rating Scale L-SRS) | Intra-operative (from T0 incision until Tend = start dressing) |
| Abdominal insufflation duration in minutes | To compare the time in minutes spent with abdominal insufflation and laparoscopic surgery between group D and M | Intra-operative (from T0 incision until Tend = start dressing) |
| Time for awakening and extubation in seconds | To compare the time for awakening and extubation (performed for all patients in the Operating Room, OR) between group D and M | Intra-operative (from T0 incision until Tend = start dressing) |
| Pain score at rest on a scale from 0 to 10 | To compare maximal postoperative pain scores (Numeric Rating Scale, NRS) at: arrival in postanesthesia care unit (PACU), and every 15 min until PACU discharge at rest and coughing/mobilization | every 15 minutes until discharge from PACU, up to 3 hours |
| Pain score at coughing/mobilization on a scale from 0 to 10 | To compare maximal postoperative pain scores (Numeric Rating Scale, NRS) at: arrival in postanesthesia care unit (PACU), and every 15 min until PACU discharge at rest and coughing/mobilization | every 15 minutes until discharge from PACU, up to 3 hours |
| Pain score at the shoulder on a scale from 0 to 10 | To compare the incidence of shoulder pain and intensity (maximal NRS score at the shoulder) in PACU at arrival then every 15 minutes, between group D versus M | every 15 minutes until discharge from PACU, up to 3 hours |
| Postoperative Hydromorphone consumption in mg in Postoperative Care Unit (PACU) | To compare the total amount of hydromorphone (in mg) given IV in PACU as a pain killer titration following a strict PACU protocol to reach a NRS pain score < 4/10 between group D and M | every 15 minutes until discharge from PACU, up to 3 hours |
| Pain score at rest at 8hs on a scale from 0 to 10 | To compare maximal postoperative pain scores at rest at 8 hours after surgery between group D and M | 8 hours after surgery in hospital |
| Pain score at coughing/mobilization at 8hs on a scale from 0 to 10 | To compare maximal postoperative pain scores at coughing/movement at 8 hours after surgery between group D and M | 8 hours after surgery in hospital |
| Pain score at rest at 16hs on a scale from 0 to 10 | To compare maximal postoperative pain scores at rest at 16 hours after surgery between group D and M | 16 hours after surgery in hospital |
| Pain score at coughing/mobilization at 16hs on a scale from 0 to 10 | To compare maximal postoperative pain scores at coughing/movement at 16 hours after surgery between group D and M | 16 hours after surgery in hospital |
| Pain score at rest at 24hs on a scale from 0 to 10 | To compare maximal postoperative pain scores at rest at 24 hours after surgery between group D and M | 24 hours after surgery in hospital |
| Pain score at coughing/mobilization at 24hs on a scale from 0 to 10 | To compare maximal postoperative pain scores at coughing/movement every 24 hours after surgery between group D and M | 24 hours after surgery in hospital |
| Amount of opioids received in 24h as Patient Controlled Analgesia in mg | To compare analgesic requirements for 24 hours given as patient controlled analgesia (PCA) in mg over 24hs | 24 hours after surgery in hospital |
| Recovery score QOR15 questionnaire (150 points maximum for this questionnaire) | To compare recovery scores (QOR15) from 0 to 150 points at 24 hours after surgery | 24 hours after surgery in hospital |
| POSS postoperative Sedation score in PACU on a scale from 1 to 4 | Sedation score in PACU | every 30 minutes from T0 = arrival in PACU until discharge from PACU, up to 3 hours |
| postoperative nausea and vomiting score in PACU on a scale from 0 to 3 | nausea and vomiting score in PACU from 0 to 3 | every 30 minutes from T0 = arrival in PACU until discharge from PACU, up to 3 hours |
| postoperative Aldrete score in PACU on a scale from 5 to 15 | Recovery score in PACU to decide on the possibility of discharge of the patient from PACU | every 30 minutes from T0 = arrival in PACU until discharge from PACU, up to 3 hours |
| Reset | Aug 16, 2024 |
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jul 17, 2023 | Mar 1, 2024 | |||
| Mar 20, 2024 | Aug 16, 2024 |